Active Filter(s):
Details:
The companies will combine Aptamer’s Optimer technology with PinotBio’s technology using the chemotherapeutic FL-118 compound with specific linker.
Lead Product(s): FL-118-based Drug Conjugate
Therapeutic Area: Oncology Product Name: FL-118
Highest Development Status: Discovery Product Type: Undisclosed
Partner/Sponsor/Collaborator: PinotBio
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration June 03, 2021